Amy H Akers, MD
Neurology · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Akers’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A77523 · Current
Licensed to practise in California · since 2002 · expires 2028-01-31 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$149,528
Medicare paid this office $149,528 for 414 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Botox | 15 | $45,391 | None |
| Long return visit (40+ min) | 140 | $29,909 | $158 |
| Return visit (30+ min) | 192 | $27,953 | $110 |
| New patient visit (60+ min) | 68 | $12,752 | $188 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 15 | $7,136 | $132 |
See all 14 services
| Botox | 15 | $45,391 | None |
| Long return visit (40+ min) | 140 | $29,909 | $158 |
| Return visit (30+ min) | 192 | $27,953 | $110 |
| New patient visit (60+ min) | 68 | $12,752 | $188 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 15 | $7,136 | $132 |
| Short return visit (20+ min) | 56 | $4,790 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $3,999 | $148 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $3,335 | $104 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 150 | $3,280 | $14 |
| New patient visit (45+ min) | 12 | $1,580 | $132 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 43 | $1,454 | $29 |
| Muscle electrical test | 11 | $1,381 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $909 | $70 |
| Short return visit | 11 | $678 | $52 |
Who their Medicare patients are
414 Original Medicare patients in 2024. Average age 77 · Under 65 5% · 85 and older 23% · Women 65% · Also on Medicaid 7% · Health risk score 1.24. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 69% · Dementia 27% · Chronic kidney disease 26% · Coronary heart disease 25% · Depression 24% · Diabetes 23% · Cancer 14% · Atrial fibrillation 14% · Heart failure 11% · COPD 11% · Stroke 11%.
The office billed $533,629, Medicare allowed $198,070 and paid $149,528; for 11,449 services of 25 kinds; $45,391 of it was for drugs given in the office and $104,137 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 414 | 11,449 | 77 | 1.24 | $533,629 | $149,528 |
| 2023 | 363 | 8,512 | 77 | 1.30 | $420,442 | $123,300 |
| 2022 | 366 | 8,753 | 77 | 1.23 | $450,631 | $132,615 |
| 2021 | 383 | 5,465 | 77 | 1.16 | $373,906 | $113,406 |
| 2020 | 348 | 4,795 | 77 | 1.34 | $323,447 | $91,970 |
| 2019 | 409 | 4,111 | 78 | 1.30 | $397,517 | $110,334 |
| 2018 | 387 | 2,905 | 77 | 1.53 | $365,565 | $104,092 |
| 2017 | 339 | 5,027 | 77 | 1.53 | $322,011 | $94,043 |
| 2016 | 352 | 3,695 | 77 | 1.60 | $365,201 | $107,155 |
| 2015 | 358 | 2,033 | 77 | 1.63 | $337,920 | $103,060 |
| 2014 | 352 | 742 | 77 | 1.64 | $291,959 | $83,889 |
| 2013 | 173 | 360 | 71 | 1.31 | $151,423 | $38,518 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Botox | 12 | $32,534 | None |
| Long return visit (40+ min) | 136 | $29,798 | $154 |
| Return visit (30+ min) | 173 | $24,831 | $106 |
| New patient visit (60+ min) | 59 | $11,367 | $193 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $6,614 | $102 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 12 | $5,316 | $136 |
| Short return visit (20+ min) | 34 | $2,419 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,360 | $148 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 37 | $1,274 | $29 |
| Short return visit | 12 | $690 | $43 |
2022: 11 services
| Botox | 15 | $36,332 | None |
| Return visit (30+ min) | 165 | $27,054 | $108 |
| Long return visit (40+ min) | 117 | $24,234 | $149 |
| New patient visit (60+ min) | 73 | $13,301 | $182 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 14 | $5,861 | $140 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $3,921 | $91 |
| Short return visit (20+ min) | 47 | $3,799 | $74 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,007 | $158 |
| New patient visit (45+ min) | 24 | $2,828 | $118 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 37 | $1,193 | $29 |
| Short return visit | 18 | $1,101 | $50 |
2021: 10 services
| Return visit (30+ min) | 143 | $22,856 | $108 |
| Long return visit (40+ min) | 120 | $22,169 | $158 |
| New patient visit (60+ min) | 80 | $16,141 | $202 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $5,603 | $92 |
| Short return visit (20+ min) | 53 | $4,492 | $80 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,378 | $168 |
| New patient visit (45+ min) | 29 | $4,022 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,104 | $65 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 27 | $1,035 | $30 |
| Short return visit | 17 | $894 | $50 |
2020: 13 services
| Return visit (30+ min) | 153 | $19,212 | $92 |
| New patient visit (60+ min) | 61 | $10,533 | $173 |
| Long return visit (40+ min) | 68 | $9,212 | $121 |
| New patient visit (45+ min) | 43 | $6,075 | $141 |
| Critical care, first 30-74 minutes | 11 | $4,906 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $4,687 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,380 | $154 |
| Short return visit (20+ min) | 32 | $2,208 | $67 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,455 | $104 |
| Extended patient service without direct patient contact, first hour | 12 | $1,244 | $104 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $1,217 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $999 | $62 |
| Telephone medical discussion with physician, 5-10 minutes | 11 | $536 | $45 |
2019: 11 services
| Return visit (30+ min) | 188 | $27,932 | $93 |
| New patient visit (60+ min) | 63 | $11,356 | $180 |
| Long return visit (40+ min) | 70 | $10,400 | $125 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $8,434 | $94 |
| Critical care, first 30-74 minutes | 17 | $7,879 | $197 |
| New patient visit (45+ min) | 52 | $7,546 | $145 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $6,859 | $176 |
| Short return visit (20+ min) | 63 | $4,208 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $2,099 | $66 |
| Muscle electrical test | 16 | $2,090 | $95 |
| New patient visit (30+ min) | 11 | $1,127 | $102 |
2018: 9 services
| Return visit (30+ min) | 161 | $24,150 | $93 |
| Critical care, first 30-74 minutes | 30 | $13,202 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 73 | $11,673 | $93 |
| New patient visit (60+ min) | 59 | $10,364 | $176 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $9,502 | $176 |
| Long return visit (40+ min) | 51 | $6,343 | $113 |
| New patient visit (45+ min) | 41 | $6,080 | $148 |
| Short return visit (20+ min) | 38 | $2,852 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,617 | $65 |
2017: 9 services
| Return visit (30+ min) | 147 | $21,219 | $93 |
| New patient visit (60+ min) | 57 | $10,330 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $7,998 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $7,766 | $173 |
| Long return visit (40+ min) | 48 | $7,144 | $123 |
| New patient visit (45+ min) | 38 | $5,179 | $136 |
| Short return visit (20+ min) | 49 | $3,162 | $55 |
| Critical care, first 30-74 minutes | 11 | $2,733 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,095 | $64 |
2016: 10 services
| Return visit (30+ min) | 123 | $17,482 | $92 |
| Critical care, first 30-74 minutes | 41 | $14,731 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 62 | $12,117 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $9,971 | $178 |
| New patient visit (60+ min) | 52 | $9,187 | $177 |
| New patient visit (45+ min) | 49 | $7,165 | $146 |
| Long return visit (40+ min) | 49 | $6,934 | $124 |
| Short return visit (20+ min) | 66 | $4,877 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $3,088 | $64 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $558 | $35 |
2015: 11 services
| Critical care, first 30-74 minutes | 51 | $18,092 | $206 |
| Return visit (30+ min) | 110 | $15,023 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 71 | $12,858 | $97 |
| New patient visit (60+ min) | 65 | $12,068 | $186 |
| Long return visit (40+ min) | 62 | $10,407 | $137 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $7,549 | $189 |
| New patient visit (45+ min) | 37 | $5,428 | $147 |
| Short return visit (20+ min) | 49 | $4,578 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,438 | $68 |
| Extended office or other outpatient service, first hour | 14 | $1,328 | $95 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $657 | $33 |
2014: 10 services
| New patient visit (60+ min) | 82 | $14,560 | $178 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 81 | $10,798 | $90 |
| Critical care, first 30-74 minutes | 39 | $10,162 | $195 |
| Return visit (30+ min) | 65 | $9,046 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $8,567 | $175 |
| New patient visit (45+ min) | 59 | $8,377 | $142 |
| Long return visit (40+ min) | 41 | $5,688 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $4,744 | $64 |
| Short return visit (20+ min) | 45 | $3,820 | $67 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 28 | $1,158 | $33 |
2013: 5 services
| Return visit (30+ min) | 74 | $11,829 | $92 |
| New patient visit (60+ min) | 53 | $9,869 | $186 |
| Short return visit (20+ min) | 60 | $5,293 | $62 |
| Long return visit (40+ min) | 30 | $4,528 | $119 |
| New patient visit (45+ min) | 22 | $2,878 | $131 |
Drugs they prescribed that Part D paid
$380,903
Pharmacies billed $380,903 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (20 of 2,323) in 2024. Above the middle of the specialty; the typical neurology clinician is at 0%.
2,131 generic and fewer than 11 brand-name prescriptions · $380,903 in drug cost · 139 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rytary | Parkinson's | 21 | $44,579 | $2,123 |
| Aimovig | Migraine | 16 | $19,663 | $1,229 |
| Ubrelvy | None | 20 | $19,470 | $974 |
| Emgality | Migraine | 26 | $18,547 | $713 |
| Rasagiline Mesylate | None | 42 | $14,895 | $355 |
See all 49 drugs
| Rytary | Parkinson's | 21 | $44,579 | $2,123 |
| Aimovig | Migraine | 16 | $19,663 | $1,229 |
| Ubrelvy | None | 20 | $19,470 | $974 |
| Emgality | Migraine | 26 | $18,547 | $713 |
| Rasagiline Mesylate | None | 42 | $14,895 | $355 |
| Carbidopa-Levodopa | None | 174 | $8,020 | $46 |
| Levetiracetam | None | 91 | $5,583 | $61 |
| Dilantin | None | 17 | $5,092 | $300 |
| Zolmitriptan | None | 16 | $4,939 | $309 |
| Memantine | None | 137 | $4,349 | $32 |
| Carbamazepine Er | None | 37 | $4,268 | $115 |
| Tegretol Xr | None | 15 | $4,214 | $281 |
| Sumatriptan | None | 49 | $3,876 | $79 |
| Amantadine | None | 46 | $3,682 | $80 |
| Gabapentin | None | 146 | $3,159 | $22 |
| Donepezil | None | 176 | $2,110 | $12 |
| Lacosamide | None | 26 | $2,009 | $77 |
| Pregabalin | None | 66 | $1,798 | $27 |
| Sumatriptan | None | 13 | $1,769 | $136 |
| Propranolol Hcl Er | None | 39 | $1,604 | $41 |
| Olanzapine | None | 48 | $1,547 | $32 |
| Carbidopa-Levodopa Er | None | 53 | $1,520 | $29 |
| Entacapone | None | 21 | $1,492 | $71 |
| Escitalopram | None | 70 | $1,423 | $20 |
| Oxcarbazepine | None | 15 | $1,151 | $77 |
| Nortriptyline | None | 55 | $1,107 | $20 |
| Rizatriptan | None | 49 | $994 | $20 |
| Primidone | None | 21 | $927 | $44 |
| Quetiapine | None | 73 | $921 | $13 |
| Lamotrigine | None | 30 | $837 | $28 |
| Rivastigmine | None | 23 | $739 | $32 |
| Phenytoin Sodium Extended | None | 17 | $673 | $40 |
| Topiramate | None | 43 | $645 | $15 |
| Mirtazapine | None | 30 | $641 | $21 |
| Baclofen | None | 19 | $592 | $31 |
| Tolterodine Tartrate Er | None | 11 | $540 | $49 |
| Zonisamide | None | 12 | $534 | $44 |
| Clopidogrel | None | 18 | $457 | $25 |
| Bupropion Xl | None | 23 | $438 | $19 |
| Trihexyphenidyl | None | 17 | $354 | $21 |
| Modafinil | None | 12 | $241 | $20 |
| Propranolol | None | 23 | $226 | $10 |
| Trazodone | None | 32 | $216 | $7 |
| Atorvastatin | None | 13 | $213 | $16 |
| Sertraline | None | 25 | $198 | $8 |
| Clonazepam | None | 24 | $195 | $8 |
| Lorazepam | None | 35 | $182 | $5 |
| Prednisone | None | 15 | $91 | $6 |
| Tramadol | None | 13 | $16 | $1 |
Year by year
| 2024 | 2,323 | 363 | 1% (20) | None | $380,903 |
| 2023 | 2,306 | 346 | 1% (13) | None | $574,360 |
| 2022 | 2,375 | 370 | None | None | $586,214 |
| 2021 | 2,016 | 333 | None | None | $482,901 |
| 2020 | 1,574 | 285 | None | None | $438,147 |
| 2019 | 1,483 | 278 | None | 13% | $288,618 |
| 2018 | 1,303 | 253 | 1% (16) | 12% | $173,254 |
| 2017 | 1,207 | 214 | None | None | $230,924 |
| 2016 | 1,130 | 207 | 1% (14) | None | $210,538 |
| 2015 | 1,041 | 180 | 3% (26) | None | $200,182 |
| 2014 | 1,046 | 197 | 1% (11) | 22% | $292,505 |
| 2013 | 1,148 | 145 | 1% (11) | 25% | $379,863 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 50 drugs
| Rytary | Parkinson's | 18 | $30,477 | $1,693 |
| Ajovy | None | 13 | $25,402 | $1,954 |
| Rasagiline Mesylate | None | 48 | $20,594 | $429 |
| Emgality | Migraine | 22 | $15,996 | $727 |
| Aimovig | Migraine | 14 | $14,078 | $1,006 |
| Carbidopa-Levodopa | None | 173 | $13,634 | $79 |
| Ubrelvy | None | 11 | $11,725 | $1,066 |
| Memantine | None | 112 | $8,965 | $80 |
| Entacapone | None | 25 | $6,241 | $250 |
| Amantadine | None | 42 | $5,047 | $120 |
| Tegretol Xr | None | 16 | $4,313 | $270 |
| Gabapentin | None | 159 | $4,126 | $26 |
| Carbamazepine Er | None | 30 | $4,058 | $135 |
| Zolmitriptan | None | 19 | $3,870 | $204 |
| Pregabalin | None | 52 | $3,719 | $72 |
| Levetiracetam | None | 76 | $3,593 | $47 |
| Dilantin | None | 12 | $3,581 | $298 |
| Donepezil | None | 167 | $3,029 | $18 |
| Dimethyl | None | 11 | $2,863 | $260 |
| Carbidopa-Levodopa Er | None | 53 | $2,638 | $50 |
| Propranolol Hcl Er | None | 41 | $2,634 | $64 |
| Duloxetine | None | 16 | $2,248 | $141 |
| Lacosamide | None | 22 | $2,131 | $97 |
| Olanzapine | None | 38 | $2,034 | $54 |
| Rizatriptan | None | 68 | $1,966 | $29 |
| Tolterodine Tartrate Er | None | 12 | $1,964 | $164 |
| Sumatriptan | None | 53 | $1,729 | $33 |
| Nortriptyline | None | 42 | $1,698 | $40 |
| Rivastigmine | None | 24 | $1,307 | $54 |
| Primidone | None | 31 | $1,298 | $42 |
| Topiramate | None | 48 | $1,231 | $26 |
| Quetiapine | None | 74 | $1,130 | $15 |
| Escitalopram | None | 59 | $951 | $16 |
| Mirtazapine | None | 49 | $805 | $16 |
| Phenytoin Sodium Extended | None | 16 | $766 | $48 |
| Lamotrigine | None | 20 | $704 | $35 |
| Propranolol | None | 22 | $548 | $25 |
| Pramipexole Dihydrochloride | None | 17 | $463 | $27 |
| Bupropion Xl | None | 21 | $410 | $20 |
| Trihexyphenidyl | None | 21 | $396 | $19 |
| Midodrine | None | 11 | $340 | $31 |
| Trazodone | None | 41 | $309 | $8 |
| Baclofen | None | 16 | $291 | $18 |
| Prednisone | None | 23 | $239 | $10 |
| Sertraline | None | 15 | $204 | $14 |
| Lorazepam | None | 34 | $198 | $6 |
| Clopidogrel | None | 12 | $177 | $15 |
| Atorvastatin | None | 18 | $167 | $9 |
| Bupropion Hcl Sr | None | 13 | $153 | $12 |
| Clonazepam | None | 19 | $152 | $8 |
2022: 50 drugs
| Avonex | None | 13 | $103,927 | $7,994 |
| Ingrezza | None | 12 | $83,284 | $6,940 |
| Rytary | Parkinson's | 22 | $35,310 | $1,605 |
| Aimovig | Migraine | 19 | $18,193 | $958 |
| Rasagiline Mesylate | None | 36 | $14,664 | $407 |
| Carbidopa-Levodopa | None | 215 | $13,207 | $61 |
| Memantine | None | 131 | $9,513 | $73 |
| Gabapentin | None | 189 | $6,592 | $35 |
| Lacosamide | None | 14 | $5,360 | $383 |
| Carbamazepine Er | None | 31 | $5,341 | $172 |
| Levetiracetam | None | 114 | $4,941 | $43 |
| Sumatriptan | None | 47 | $4,617 | $98 |
| Amantadine | None | 29 | $4,443 | $153 |
| Dilantin | None | 16 | $4,356 | $272 |
| Duloxetine | None | 29 | $4,284 | $148 |
| Zolmitriptan | None | 19 | $4,166 | $219 |
| Pregabalin | None | 46 | $3,914 | $85 |
| Dimethyl | None | 12 | $3,088 | $257 |
| Tolterodine Tartrate Er | None | 12 | $2,602 | $217 |
| Donepezil | None | 146 | $2,573 | $18 |
| Tegretol Xr | None | 13 | $2,174 | $167 |
| Propranolol Hcl Er | None | 34 | $2,169 | $64 |
| Nortriptyline | None | 75 | $2,131 | $28 |
| Carbidopa-Levodopa Er | None | 45 | $1,799 | $40 |
| Escitalopram | None | 80 | $1,610 | $20 |
| Entacapone | None | 12 | $1,545 | $129 |
| Quetiapine | None | 51 | $1,510 | $30 |
| Rivastigmine | None | 16 | $1,327 | $83 |
| Phenytoin Sodium Extended | None | 25 | $1,293 | $52 |
| Rizatriptan | None | 54 | $1,274 | $24 |
| Olanzapine | None | 21 | $1,173 | $56 |
| Lamotrigine | None | 24 | $989 | $41 |
| Pyridostigmine | None | 12 | $883 | $74 |
| Topiramate | None | 50 | $851 | $17 |
| Mirtazapine | None | 63 | $794 | $13 |
| Primidone | None | 24 | $684 | $28 |
| Bupropion Xl | None | 19 | $602 | $32 |
| Ropinirole | None | 14 | $498 | $36 |
| Trazodone | None | 45 | $477 | $11 |
| Propranolol | None | 22 | $456 | $21 |
| Pramipexole Dihydrochloride | None | 11 | $436 | $40 |
| Clopidogrel | None | 20 | $422 | $21 |
| Prednisone | None | 18 | $399 | $22 |
| Baclofen | None | 15 | $337 | $22 |
| Trihexyphenidyl | None | 30 | $329 | $11 |
| Atorvastatin | None | 30 | $272 | $9 |
| Lorazepam | None | 35 | $236 | $7 |
| Sertraline | None | 18 | $233 | $13 |
| Ezetimibe | None | 13 | $203 | $16 |
| Clonazepam | None | 17 | $184 | $11 |
2021: 49 drugs
| Ingrezza | None | 12 | $88,573 | $7,381 |
| Avonex | None | 11 | $84,809 | $7,710 |
| Vimpat | None | 27 | $47,203 | $1,748 |
| Rytary | Parkinson's | 14 | $31,506 | $2,250 |
| Carbidopa-Levodopa | None | 192 | $13,599 | $71 |
| Rasagiline Mesylate | None | 21 | $10,438 | $497 |
| Dimethyl | None | 13 | $9,059 | $697 |
| Aimovig | Migraine | 12 | $8,802 | $734 |
| Memantine | None | 106 | $6,945 | $66 |
| Levetiracetam | None | 93 | $5,589 | $60 |
| Amantadine | None | 45 | $4,977 | $111 |
| Gabapentin | None | 167 | $4,329 | $26 |
| Tegretol Xr | None | 18 | $4,194 | $233 |
| Pregabalin | None | 23 | $3,690 | $160 |
| Dilantin | None | 13 | $3,520 | $271 |
| Carbamazepine Er | None | 12 | $3,186 | $265 |
| Sumatriptan | None | 34 | $2,766 | $81 |
| Donepezil | None | 164 | $2,583 | $16 |
| Nortriptyline | None | 97 | $2,307 | $24 |
| Duloxetine | None | 15 | $2,078 | $139 |
| Olanzapine Odt | None | 20 | $2,010 | $100 |
| Phenytoin Sodium Extended | None | 24 | $1,437 | $60 |
| Rizatriptan | None | 53 | $1,391 | $26 |
| Propranolol Hcl Er | None | 28 | $1,301 | $46 |
| Carbidopa-Levodopa Er | None | 14 | $1,049 | $75 |
| Quetiapine | None | 60 | $1,044 | $17 |
| Oxcarbazepine | None | 11 | $999 | $91 |
| Mirtazapine | None | 65 | $945 | $15 |
| Primidone | None | 20 | $875 | $44 |
| Bupropion Xl | None | 31 | $874 | $28 |
| Pyridostigmine | None | 16 | $716 | $45 |
| Escitalopram | None | 35 | $663 | $19 |
| Mycophenolate Mofetil | None | 12 | $585 | $49 |
| Sertraline | None | 57 | $580 | $10 |
| Baclofen | None | 13 | $537 | $41 |
| Lamotrigine | None | 14 | $532 | $38 |
| Propranolol | None | 11 | $479 | $44 |
| Trazodone | None | 41 | $350 | $9 |
| Atorvastatin | None | 25 | $345 | $14 |
| Pramipexole Dihydrochloride | None | 15 | $327 | $22 |
| Olanzapine | None | 12 | $282 | $24 |
| Lorazepam | None | 36 | $276 | $8 |
| Clopidogrel | None | 13 | $236 | $18 |
| Prednisone | None | 11 | $204 | $19 |
| Citalopram Hbr | None | 20 | $189 | $9 |
| Clonazepam | None | 19 | $173 | $9 |
| Topiramate | None | 19 | $159 | $8 |
| Trihexyphenidyl | None | 20 | $151 | $8 |
| Oxybutynin Chloride | None | 11 | $141 | $13 |
2020: 33 drugs
| Ingrezza | None | 13 | $92,057 | $7,081 |
| Vimpat | None | 20 | $23,519 | $1,176 |
| Aimovig | Migraine | 24 | $17,302 | $721 |
| Zomig | None | 16 | $15,048 | $941 |
| Carbidopa-Levodopa | None | 151 | $12,078 | $80 |
| Rasagiline Mesylate | None | 11 | $6,825 | $620 |
| Memantine | None | 79 | $4,937 | $62 |
| Levetiracetam | None | 84 | $4,372 | $52 |
| Gabapentin | None | 148 | $4,168 | $28 |
| Amantadine | None | 41 | $3,208 | $78 |
| Duloxetine | None | 22 | $2,885 | $131 |
| Pregabalin | None | 20 | $2,643 | $132 |
| Olanzapine Odt | None | 18 | $2,469 | $137 |
| Sumatriptan | None | 31 | $2,371 | $76 |
| Donepezil | None | 126 | $2,084 | $17 |
| Nortriptyline | None | 51 | $1,338 | $26 |
| Phenytoin Sodium Extended | None | 20 | $1,156 | $58 |
| Rizatriptan | None | 45 | $1,066 | $24 |
| Propranolol Hcl Er | None | 19 | $923 | $49 |
| Primidone | None | 22 | $868 | $39 |
| Mycophenolate Mofetil | None | 13 | $824 | $63 |
| Lamotrigine | None | 17 | $726 | $43 |
| Mirtazapine | None | 38 | $673 | $18 |
| Bupropion Xl | None | 19 | $584 | $31 |
| Sertraline | None | 45 | $443 | $10 |
| Quetiapine | None | 37 | $409 | $11 |
| Atorvastatin | None | 29 | $344 | $12 |
| Escitalopram | None | 19 | $254 | $13 |
| Citalopram Hbr | None | 27 | $214 | $8 |
| Lorazepam | None | 31 | $155 | $5 |
| Propranolol | None | 12 | $134 | $11 |
| Trazodone | None | 19 | $127 | $7 |
| Trihexyphenidyl | None | 16 | $95 | $6 |
2019: 34 drugs
| Vimpat | None | 30 | $35,045 | $1,168 |
| Zomig | None | 13 | $16,310 | $1,255 |
| Aimovig | Migraine | 22 | $14,457 | $657 |
| Lyrica | None | 14 | $12,691 | $907 |
| Rasagiline Mesylate | None | 12 | $11,451 | $954 |
| Carbidopa-Levodopa-Entacapone | None | 28 | $10,450 | $373 |
| Carbidopa-Levodopa | None | 137 | $8,514 | $62 |
| Memantine | None | 75 | $7,206 | $96 |
| Gabapentin | None | 143 | $4,880 | $34 |
| Sumatriptan | None | 36 | $4,089 | $114 |
| Levetiracetam | None | 94 | $3,763 | $40 |
| Duloxetine | None | 20 | $3,322 | $166 |
| Amantadine | None | 36 | $3,048 | $85 |
| Pregabalin | None | 11 | $2,974 | $270 |
| Verapamil Er Pm | None | 22 | $2,542 | $116 |
| Donepezil | None | 123 | $1,840 | $15 |
| Nortriptyline | None | 49 | $1,571 | $32 |
| Phenytoin Sodium Extended | None | 21 | $1,350 | $64 |
| Primidone | None | 43 | $899 | $21 |
| Rizatriptan | None | 33 | $812 | $25 |
| Propranolol Hcl Er | None | 15 | $800 | $53 |
| Carbidopa-Levodopa Er | None | 11 | $772 | $70 |
| Mycophenolate Mofetil | None | 13 | $730 | $56 |
| Pyridostigmine | None | 11 | $683 | $62 |
| Escitalopram | None | 29 | $657 | $23 |
| Atorvastatin | None | 25 | $386 | $15 |
| Divalproex | None | 12 | $363 | $30 |
| Citalopram Hbr | None | 36 | $272 | $8 |
| Mirtazapine | None | 16 | $258 | $16 |
| Quetiapine | None | 25 | $227 | $9 |
| Clonazepam | None | 15 | $221 | $15 |
| Sertraline | None | 30 | $220 | $7 |
| Lorazepam | None | 30 | $113 | $4 |
| Trazodone | None | 13 | $93 | $7 |
2018: 32 drugs
| Lyrica | 21 | $22,649 | $1,079 |
| Vimpat | 21 | $22,631 | $1,078 |
| Zomig | 14 | $19,830 | $1,416 |
| Rasagiline Mesylate | 18 | $16,285 | $905 |
| Carbidopa-Levodopa-Entacapone | 20 | $10,847 | $542 |
| Carbidopa-Levodopa | 136 | $6,913 | $51 |
| Memantine | 78 | $5,445 | $70 |
| Gabapentin | 140 | $4,811 | $34 |
| Tegretol Xr | 15 | $3,795 | $253 |
| Duloxetine | 23 | $2,963 | $129 |
| Levetiracetam | 60 | $1,743 | $29 |
| Carbamazepine Er | 18 | $1,706 | $95 |
| Amantadine | 20 | $1,375 | $69 |
| Pyridostigmine | 16 | $1,344 | $84 |
| Nortriptyline | 42 | $1,212 | $29 |
| Phenytoin Sodium Extended | 12 | $1,177 | $98 |
| Donepezil | 107 | $1,072 | $10 |
| Sumatriptan | 36 | $941 | $26 |
| Rizatriptan | 15 | $938 | $63 |
| Mycophenolate Mofetil | 11 | $560 | $51 |
| Primidone | 15 | $480 | $32 |
| Escitalopram | 41 | $478 | $12 |
| Pramipexole Dihydrochloride | 17 | $476 | $28 |
| Pravastatin | 14 | $463 | $33 |
| Ropinirole Er | 11 | $291 | $26 |
| Quetiapine | 18 | $274 | $15 |
| Lamotrigine | 12 | $240 | $20 |
| Citalopram Hbr | 42 | $210 | $5 |
| Lorazepam | 30 | $152 | $5 |
| Prednisone | 18 | $119 | $7 |
| Atorvastatin | 13 | $109 | $8 |
| Sertraline | 12 | $77 | $6 |
2017: 24 drugs
| Zomig | 19 | $32,687 | $1,720 |
| Rasagiline Mesylate | 27 | $15,165 | $562 |
| Stalevo 200 | 11 | $9,596 | $872 |
| Carbidopa-Levodopa-Entacapone | 21 | $6,133 | $292 |
| Carbidopa-Levodopa | 138 | $5,560 | $40 |
| Memantine | 63 | $5,263 | $84 |
| Eliquis | 11 | $4,219 | $384 |
| Gabapentin | 114 | $2,810 | $25 |
| Duloxetine | 29 | $2,078 | $72 |
| Sumatriptan | 49 | $2,057 | $42 |
| Tegretol Xr | 12 | $1,666 | $139 |
| Levetiracetam | 50 | $1,370 | $27 |
| Phenytoin Sodium Extended | 16 | $1,207 | $75 |
| Nortriptyline | 50 | $1,059 | $21 |
| Carbamazepine Er | 12 | $979 | $82 |
| Donepezil | 92 | $928 | $10 |
| Escitalopram | 47 | $409 | $9 |
| Lamotrigine | 26 | $275 | $11 |
| Ropinirole | 12 | $229 | $19 |
| Pravastatin | 14 | $225 | $16 |
| Clopidogrel | 11 | $183 | $17 |
| Sertraline | 26 | $139 | $5 |
| Lorazepam | 20 | $76 | $4 |
| Citalopram Hbr | 12 | $47 | $4 |
2016: 25 drugs
| Zomig | 22 | $34,070 | $1,549 |
| Azilect | 23 | $21,780 | $947 |
| Lyrica | 18 | $15,573 | $865 |
| Neupro | 20 | $11,305 | $565 |
| Memantine | 39 | $4,856 | $125 |
| Entacapone | 13 | $4,073 | $313 |
| Gabapentin | 139 | $3,553 | $26 |
| Sumatriptan | 46 | $3,412 | $74 |
| Carbamazepine Er | 16 | $3,142 | $196 |
| Carbidopa-Levodopa | 101 | $2,111 | $21 |
| Levetiracetam | 80 | $2,091 | $26 |
| Tegretol Xr | 11 | $1,726 | $157 |
| Duloxetine | 24 | $1,126 | $47 |
| Donepezil | 100 | $1,074 | $11 |
| Pramipexole Dihydrochloride | 16 | $808 | $50 |
| Nortriptyline | 50 | $745 | $15 |
| Oxcarbazepine | 12 | $466 | $39 |
| Propranolol | 12 | $324 | $27 |
| Acetazolamide | 12 | $300 | $25 |
| Lamotrigine | 23 | $269 | $12 |
| Citalopram Hbr | 38 | $206 | $5 |
| Escitalopram | 14 | $154 | $11 |
| Lorazepam | 13 | $111 | $9 |
| Clonazepam | 13 | $81 | $6 |
| Sertraline | 11 | $39 | $4 |
2015: 26 drugs
| Copaxone | 12 | $77,652 | $6,471 |
| Zomig | 19 | $26,691 | $1,405 |
| Lyrica | 20 | $15,171 | $759 |
| Neupro | 19 | $9,936 | $523 |
| Namenda Xr | 17 | $6,659 | $392 |
| Acetazolamide | 12 | $2,515 | $210 |
| Gabapentin | 134 | $2,358 | $18 |
| Carbamazepine Er | 13 | $2,252 | $173 |
| Carbidopa-Levodopa | 59 | $2,133 | $36 |
| Pramipexole Dihydrochloride | 33 | $2,042 | $62 |
| Duloxetine | 30 | $1,960 | $65 |
| Levetiracetam | 66 | $1,588 | $24 |
| Rizatriptan | 18 | $1,582 | $88 |
| Donepezil | 105 | $1,039 | $10 |
| Nortriptyline | 59 | $879 | $15 |
| Propranolol Hcl Er | 16 | $691 | $43 |
| Sumatriptan | 24 | $507 | $21 |
| Quetiapine | 27 | $478 | $18 |
| Topiramate | 11 | $440 | $40 |
| Escitalopram | 17 | $309 | $18 |
| Propranolol | 16 | $206 | $13 |
| Naproxen | 16 | $151 | $9 |
| Atorvastatin | 11 | $141 | $13 |
| Citalopram Hbr | 26 | $117 | $5 |
| Acetaminophen-Codeine | 12 | $97 | $8 |
| Clopidogrel | 12 | $70 | $6 |
2014: 30 drugs
| Copaxone | 28 | $149,534 | $5,340 |
| Zomig | 24 | $28,466 | $1,186 |
| Azilect | 31 | $16,783 | $541 |
| Lyrica | 28 | $9,683 | $346 |
| Namenda | 18 | $8,871 | $493 |
| Entacapone | 20 | $7,307 | $365 |
| Namenda Xr | 18 | $6,027 | $335 |
| Neupro | 11 | $5,451 | $496 |
| Carbidopa-Levodopa | 74 | $4,037 | $55 |
| Duloxetine | 26 | $3,134 | $121 |
| Acetazolamide | 12 | $3,048 | $254 |
| Levetiracetam | 61 | $2,053 | $34 |
| Donepezil | 106 | $1,965 | $19 |
| Ropinirole | 20 | $1,961 | $98 |
| Gabapentin | 89 | $1,852 | $21 |
| Tizanidine | 11 | $1,223 | $111 |
| Rizatriptan | 11 | $1,099 | $100 |
| Pramipexole Dihydrochloride | 30 | $1,011 | $34 |
| Carbamazepine Xr | 12 | $992 | $83 |
| Carbidopa-Levodopa Er | 16 | $708 | $44 |
| Nortriptyline | 60 | $707 | $12 |
| Oxcarbazepine | 11 | $641 | $58 |
| Quetiapine | 11 | $466 | $42 |
| Sumatriptan | 21 | $438 | $21 |
| Mirtazapine | 20 | $283 | $14 |
| Topiramate | 16 | $223 | $14 |
| Citalopram Hbr | 21 | $136 | $6 |
| Naproxen | 13 | $131 | $10 |
| Lorazepam | 18 | $130 | $7 |
| Propranolol | 17 | $108 | $6 |
2013: 28 drugs
| Copaxone | 35 | $185,130 | $5,289 |
| Azilect | 61 | $28,553 | $468 |
| Lamictal Xr | 12 | $14,311 | $1,193 |
| Lyrica | 24 | $10,914 | $455 |
| Namenda | 32 | $10,861 | $339 |
| Carbidopa-Levodopa | 139 | $7,353 | $53 |
| Vimpat | 13 | $6,485 | $499 |
| Cymbalta | 22 | $5,766 | $262 |
| Entacapone | 13 | $3,629 | $279 |
| Donepezil | 79 | $3,307 | $42 |
| Gabapentin | 90 | $2,823 | $31 |
| Levetiracetam | 44 | $2,558 | $58 |
| Pramipexole Dihydrochloride | 25 | $2,153 | $86 |
| Tizanidine | 16 | $1,671 | $104 |
| Propranolol | 51 | $1,419 | $28 |
| Nortriptyline | 67 | $959 | $14 |
| Sumatriptan | 30 | $634 | $21 |
| Mirtazapine | 32 | $495 | $15 |
| Voltaren | 12 | $461 | $38 |
| Citalopram Hbr | 47 | $348 | $7 |
| Imipramine | 12 | $296 | $25 |
| Baclofen | 12 | $290 | $24 |
| Topiramate | 16 | $277 | $17 |
| Ropinirole | 13 | $254 | $20 |
| Carbidopa-Levodopa Er | 11 | $237 | $22 |
| Amitriptyline | 19 | $171 | $9 |
| Clonazepam | 14 | $157 | $11 |
| Lorazepam | 15 | $55 | $4 |
Money from drug and device companies
$122 in 2023
| 2023 | 1 | 1 | None | $122 |
| 2022 | 1 | 1 | None | $34 |
| 2019 | 1 | 1 | None | $27 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| SK Life Science | Xcopri | $122 | 1 payment
|
See the published payment
| SK Life Science | Meals · 2023-01-30 | Xcopri | $122 |
See earlier years (2022, 2019)
2022: $34
| EMD Serono | Mavenclad | $34 | 1 payment
|
2019: $27
| Amgen | Aimovig | $27 | 1 payment
|
Professional record
- NPI
- 1699792655
- Licence
- CA A77523California A77523: Current · expires 2028-01-31
- Trained
- Harvard Medical School, 2000
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-07-16
- NPI last updated
- 2020-06-22
- NPI record certified
- 2020-06-22
This is when the NPI record was last certified, not a medical board exam.